DE2920562A1 - Verfahren zur herstellung von 5-halogen-6,9 alpha -oxydo-prostaglandin- derivaten - Google Patents
Verfahren zur herstellung von 5-halogen-6,9 alpha -oxydo-prostaglandin- derivatenInfo
- Publication number
- DE2920562A1 DE2920562A1 DE19792920562 DE2920562A DE2920562A1 DE 2920562 A1 DE2920562 A1 DE 2920562A1 DE 19792920562 DE19792920562 DE 19792920562 DE 2920562 A DE2920562 A DE 2920562A DE 2920562 A1 DE2920562 A1 DE 2920562A1
- Authority
- DE
- Germany
- Prior art keywords
- electrochemical oxidation
- general formula
- optionally
- group
- oxydo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 23
- 238000002360 preparation method Methods 0.000 title claims description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 15
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 11
- 238000006056 electrooxidation reaction Methods 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- 150000003180 prostaglandins Chemical class 0.000 claims description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 239000003513 alkali Substances 0.000 claims description 6
- -1 halide ions Chemical class 0.000 claims description 6
- 125000006239 protecting group Chemical group 0.000 claims description 6
- 239000011541 reaction mixture Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 150000002892 organic cations Chemical class 0.000 claims description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 150000002825 nitriles Chemical class 0.000 claims description 4
- 229910052697 platinum Inorganic materials 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 125000001424 substituent group Chemical group 0.000 claims description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 150000001767 cationic compounds Chemical class 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 229910001411 inorganic cation Inorganic materials 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 239000003586 protic polar solvent Substances 0.000 claims description 3
- DZUXGQBLFALXCR-UHFFFAOYSA-N (+)-(9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprost-13-en-1-oic acid Natural products CCCCCC(O)C=CC1C(O)CC(O)C1CCCCCCC(O)=O DZUXGQBLFALXCR-UHFFFAOYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 2
- 239000000337 buffer salt Substances 0.000 claims description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052737 gold Inorganic materials 0.000 claims description 2
- 239000010931 gold Substances 0.000 claims description 2
- 125000005842 heteroatom Chemical group 0.000 claims description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 2
- 150000007522 mineralic acids Chemical class 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 229910052763 palladium Inorganic materials 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 2
- 125000003107 substituted aryl group Chemical group 0.000 claims description 2
- 229910052719 titanium Inorganic materials 0.000 claims description 2
- 239000010936 titanium Substances 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 1
- 125000001246 bromo group Chemical group Br* 0.000 claims 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 claims 1
- 229940006461 iodide ion Drugs 0.000 claims 1
- 238000005868 electrolysis reaction Methods 0.000 description 6
- 238000005658 halogenation reaction Methods 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 150000001768 cations Chemical class 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000026030 halogenation Effects 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000003792 electrolyte Substances 0.000 description 4
- 150000003842 bromide salts Chemical class 0.000 description 3
- 150000004702 methyl esters Chemical class 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 238000006704 dehydrohalogenation reaction Methods 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 150000004694 iodide salts Chemical class 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000006798 ring closing metathesis reaction Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 241000224511 Bodo Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical group 0.000 description 1
- 125000005103 alkyl silyl group Chemical group 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000004982 aromatic amines Chemical group 0.000 description 1
- 150000003975 aryl alkyl amines Chemical group 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000026045 iodination Effects 0.000 description 1
- 238000006192 iodination reaction Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- HSZCZNFXUDYRKD-UHFFFAOYSA-M lithium iodide Chemical class [Li+].[I-] HSZCZNFXUDYRKD-UHFFFAOYSA-M 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000004010 onium ions Chemical class 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
- C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU78CI1832A HU179001B (en) | 1978-05-29 | 1978-05-29 | Process for preparing 5-halo-6,9alpha-oxido-prostaglandin derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2920562A1 true DE2920562A1 (de) | 1979-12-06 |
| DE2920562C2 DE2920562C2 (en, 2012) | 1989-01-19 |
Family
ID=10994698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19792920562 Granted DE2920562A1 (de) | 1978-05-29 | 1979-05-21 | Verfahren zur herstellung von 5-halogen-6,9 alpha -oxydo-prostaglandin- derivaten |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4233121A (en, 2012) |
| JP (1) | JPS54163592A (en, 2012) |
| AT (1) | AT374831B (en, 2012) |
| DE (1) | DE2920562A1 (en, 2012) |
| GB (1) | GB2027014B (en, 2012) |
| GR (1) | GR68433B (en, 2012) |
| HU (1) | HU179001B (en, 2012) |
| IT (1) | IT1165207B (en, 2012) |
| SU (1) | SU890974A3 (en, 2012) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5230783A (en) * | 1991-05-15 | 1993-07-27 | The Dow Chemical Company | Electrolytic cell and process for the labeling of proteins and peptides |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4290862A (en) * | 1979-11-14 | 1981-09-22 | Edinen Centar P Chimia | Method for the preparation of narwedine-type enones |
| IL65387A0 (en) * | 1981-04-14 | 1982-05-31 | Chinoin Gyogyszer Es Vegyeszet | 2,3,4-trinor-m-inter-phenylene-prostaglandin derivatives and a process for the preparation thereof |
| HU184948B (en) * | 1981-04-14 | 1984-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing 5-substituted 4-oxo-pgi down 1 derivatives |
| HU190007B (en) * | 1982-05-06 | 1986-08-28 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu | Process for producing new aromatic prostacylin analogues |
| US4510025A (en) * | 1983-08-24 | 1985-04-09 | Kuraray Company, Ltd. | Method for production of 3-substituted-2,2-dimethylbicyclo[2.2.1]heptan-5-ols and esters thereof |
| US4670109A (en) * | 1985-01-25 | 1987-06-02 | Firmenich Sa | Process for the preparation of isoxazoles |
| EP1178083A4 (en) * | 1999-12-17 | 2002-05-29 | Hayashibara Biochem Lab | Cyanine dye |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3427235A (en) * | 1965-01-15 | 1969-02-11 | Pullman Inc | Electrolytic production of olefine oxides |
| IL51189A (en) | 1976-02-04 | 1985-08-30 | Upjohn Co | Prostaglandin analogs |
| US4125712A (en) * | 1976-06-01 | 1978-11-14 | The Upjohn Company | Certain 5,6-dihydro-prostacyclin analogs |
-
1978
- 1978-05-29 HU HU78CI1832A patent/HU179001B/hu unknown
-
1979
- 1979-05-15 GR GR59087A patent/GR68433B/el unknown
- 1979-05-21 DE DE19792920562 patent/DE2920562A1/de active Granted
- 1979-05-21 AT AT0371479A patent/AT374831B/de not_active IP Right Cessation
- 1979-05-21 US US06/041,104 patent/US4233121A/en not_active Expired - Lifetime
- 1979-05-24 IT IT68106/79A patent/IT1165207B/it active
- 1979-05-25 GB GB7918487A patent/GB2027014B/en not_active Expired
- 1979-05-28 SU SU792773053A patent/SU890974A3/ru active
- 1979-05-28 JP JP6509279A patent/JPS54163592A/ja active Granted
Non-Patent Citations (2)
| Title |
|---|
| Tetrahedron Lett. 30 (1977), 2627-2628 * |
| Tetrahedron Lett. 39 (1971), 3599-3602 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5230783A (en) * | 1991-05-15 | 1993-07-27 | The Dow Chemical Company | Electrolytic cell and process for the labeling of proteins and peptides |
| US5246561A (en) * | 1991-05-15 | 1993-09-21 | The Dow Chemical Company | Electrolytic cell and process for the labeling of proteins and peptides |
Also Published As
| Publication number | Publication date |
|---|---|
| ATA371479A (de) | 1983-10-15 |
| US4233121A (en) | 1980-11-11 |
| GR68433B (en, 2012) | 1981-12-30 |
| JPS62999B2 (en, 2012) | 1987-01-10 |
| IT7968106A0 (it) | 1979-05-24 |
| HU179001B (en) | 1982-08-28 |
| DE2920562C2 (en, 2012) | 1989-01-19 |
| GB2027014B (en) | 1982-08-25 |
| IT1165207B (it) | 1987-04-22 |
| JPS54163592A (en) | 1979-12-26 |
| AT374831B (de) | 1984-06-12 |
| GB2027014A (en) | 1980-02-13 |
| SU890974A3 (ru) | 1981-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0012215B1 (de) | 2-Hydroxybutansulfonsaures Cholin und dessen Verwendung als Leitsalz | |
| DE1246734B (de) | Verfahren zur elektrolytischen Herstellung von Bleitetraalkylen an einer Aufbrauchkathode | |
| DE2458164A1 (de) | Verfahren zur herstellung von neuen heterocyclischen verbindungen | |
| DE2920562C2 (en, 2012) | ||
| CH618686A5 (en, 2012) | ||
| DE1227914B (de) | Verfahren zur Herstellung von 3-(1, 2-Dithia-cyclopentyl)-5-pentansaeure | |
| DE1172671B (de) | Verfahren zur Herstellung von 17ª-Hydroxy-androstan-(3, 2-c)-pyrazol oder eines 17ª-Hydroxy-17ª-niederes-Alkyl-androstan-(3, 2-c)-pyrazols | |
| DE1085159B (de) | Verfahren zur Herstellung von N, N-Diisopropylbenzthiazolyl-2-sulfenamid | |
| DE69900927T2 (de) | Verfahren zur Herstellung von 4-(des-dimethylamino)-Tetracyclinen | |
| DE2948116A1 (de) | Verfahren zur herstellung von apovincaminsaeureester-derivaten | |
| DE2558158C2 (de) | Verfahren zur Herstellung von threo-Threonin | |
| DE1793693A1 (de) | Verfahren zur Herstellung von Adamantanverbindungen | |
| DE3026602A1 (de) | 14-oxo-15-halogen-e-homoeburnanderivate, verfahren zur herstellung derselben und von 14-oxo-15-hydroxyimino-e-homoeburnanderivaten und die ersteren enthaltende arzneimittel | |
| DE2808006A1 (de) | Verfahren zur herstellung von prostacyclin und seinen analogen | |
| DE1114815B (de) | Verfahren zur Herstellung von Ferrocenderivaten | |
| CH642660A5 (en) | Process for the preparation of enones of the narwedine type and their derivatives | |
| DE1695667A1 (de) | Neue Pyrrolderivate,deren Herstellung und deren Verwendung | |
| DE857501C (de) | Verfahren zur Herstellung von Disulfiden | |
| DE2058237C (en, 2012) | ||
| EP0085158B1 (de) | Verfahren zur Herstellung von Cycloalkenonderivaten | |
| DE2430273A1 (de) | Verfahren zur herstellung von primaeren halogeniden von 2,6,6-trisubstituierten cyclohexen-polyenderivaten | |
| DE914973C (de) | Verfahren zur Herstellung von substituierten threo-konfigurierten ª‡-Halogen-ª‰-oxy-acylamino-aethanen | |
| DE1793711B2 (de) | Verfahren zur Herstellung eines ungesättigten Aldehyds | |
| DE2661074C2 (de) | Halogenierte Benzylalkohole | |
| DE1543696C (de) | Octahydro l,3a,6 tnmethyl IH 1,6a athanopentaleno (1,2 C) furan und Verfah ren zu seiner Herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |